BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3037172)

  • 1. Converting enzyme inhibitors and renal function in cardiac failure.
    Robertson JI; Richards AM
    Kidney Int Suppl; 1987 May; 20():S216-9. PubMed ID: 3037172
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the renin-angiotensin system on cardiac diseases.
    De Mello WC
    P R Health Sci J; 1996 Sep; 15(3):193-4. PubMed ID: 8994284
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac failure, the kidney, renin and atrial peptides.
    Robertson JI; Richards AM
    Eur Heart J; 1988 Jun; 9 Suppl H():11-4. PubMed ID: 2971538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins, renin and atrial natriuretic peptide in the control of the circulation and renal function in heart failure in the dog.
    Riegger GA; Elsner D; Hildenbrand J; Koch K; Kromer EP
    Prog Clin Biol Res; 1989; 301():455-8. PubMed ID: 2529553
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart failure and circulatory control peptides].
    Takeshita A
    Nihon Naika Gakkai Zasshi; 1994 Jan; 83(1):138-42. PubMed ID: 9132444
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances.
    Weinberg MS
    Clin Ther; 1993; 15(1):3-17; discussion 2. PubMed ID: 8458051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
    Johnston CI; Fabris B; Jandeleit K
    Kidney Int Suppl; 1993 Jul; 42():S59-63. PubMed ID: 8361131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin angiotensin system antagonists and anesthesia.
    Colson P; Ryckwaert F; Coriat P
    Anesth Analg; 1999 Nov; 89(5):1143-55. PubMed ID: 10553825
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal failure related to angiotensin-converting enzyme inhibitors.
    Textor SC
    Semin Nephrol; 1997 Jan; 17(1):67-76. PubMed ID: 9000551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental models of heart failure: implications for renin and the kidney.
    Riegger GA
    Kidney Int Suppl; 1987 May; 20():S210-2. PubMed ID: 3298800
    [No Abstract]   [Full Text] [Related]  

  • 14. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system and renal circulation in clinical congestive heart failure.
    Dzau VJ
    Kidney Int Suppl; 1987 May; 20():S203-9. PubMed ID: 3037171
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac afferents and neurohormonal activation in congestive heart failure.
    Davila DF; Donis JH; Bellabarba G; Torres A; Casado J; Mazzei de Davila C
    Med Hypotheses; 2000 Feb; 54(2):242-53. PubMed ID: 10790760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
    Blankstein R; Bakris GL
    Heart Fail Clin; 2008 Oct; 4(4):425-38. PubMed ID: 18760754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.